Patent · US Active

Quinazolinone derivatives useful as vanilloid antagonists

US8349852B2 · kind B2 · utility

0Cited by

0References

5Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Weichun Chen · Zhejiang, CN
Hong-Yong Kim · Whippany, US
Jessica Liang · Annandale, US
Michael Mutz · Glückstadt, DE
Mahavir Prashad · East Hanover, US
Christopher Towler · Quincy, US
Ruoqiu Wu · East Hanover, US

Key dates

Filing date	Jan 6, 2010
Grant date	Jan 8, 2013
Priority date	—
Expiry date	Sep 7, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There is described a new polymorphic form of 4-(7-Hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile and a method of preparing it.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.